Cite

HARVARD Citation

    Gleeson, M. et al. (2017). Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003–2013. Leukemia & lymphoma. 58 (8), pp. 1805-1813. [Online]. 
  
Back to record